​

argenx SE (ARGX) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

ARGX Stock Forecast

argenx SE (ARGX) stock forecast, based on 34 Wall Street analysts, predicts a 12-month average price target of $796.75, with a high of $850.00 and a low of $699.00. This represents a 4.44% increase from the last price of $762.89.

$350 $450 $550 $650 $750 $850 High: $850 Avg: $796.75 Low: $699 Last Closed Price: $762.89

ARGX Stock Rating

argenx SE stock's rating consensus is Buy, based on 34 Wall Street analysts. The breakdown includes 1 Strong Buy (2.94%), 30 Buy (88.24%), 3 Hold (8.82%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 34 3 30 1 Strong Sell Sell Hold Buy Strong Buy

ARGX Price Target Upside V Benchmarks

TypeNameUpside
Stockargenx SE4.44%
SectorHealthcare Stocks 13.55%
IndustryBiotech Stocks 49.00%

Price Target Trends

1M3M12M
# Anlaysts338
Avg Price Target$829.33$829.33$735.38
Last Closing Price$762.89$762.89$762.89
Upside/Downside8.71%8.71%-3.61%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 256161--23
Aug, 256161--23
Jul, 257151--23
Jun, 257141--22
May, 257132--22
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 26, 2025Piper Sandler$820.00$698.9917.31%7.49%
Aug 26, 2025Jefferies$818.00$698.9917.03%7.22%
Aug 25, 2025Luca IssiRBC Capital$850.00$677.3225.49%11.42%
May 14, 2025Jason ButlerJMP Securities$699.00$560.9024.62%-8.37%
Mar 04, 2025Robert W. Baird$680.00$621.259.46%-10.87%
Jan 14, 2025Jason ButlerJMP Securities$696.00$648.627.30%-8.77%
Nov 05, 2024George FarmerScotiabank$715.00$602.4718.68%-6.28%
Oct 10, 2024Danielle BrillRaymond James$605.00$520.5216.23%-20.70%
Jul 29, 2024Joel BeattyRobert W. Baird$515.00$495.923.85%-32.49%
Jul 26, 2024Douglas TsaoH.C. Wainwright$533.00$492.078.32%-30.13%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 26, 2025Piper SandlerOverweightOverweighthold
Aug 26, 2025JefferiesBuyBuyhold
Aug 25, 2025RBC CapitalOutperforminitialise
Aug 04, 2025BarclaysOverweightOverweighthold
Aug 04, 2025Deutsche BankBuyBuyhold
May 21, 2025CitigroupBuyBuyhold
May 14, 2025CitigroupOutperformOutperformhold
Mar 12, 2025Deutsche BankHoldHoldupgrade
Feb 28, 2025OppenheimerOutperformOutperformhold
Feb 28, 2025CitigroupOutperformOutperformhold

Financial Forecast

EPS Forecast

$-20 $-7 $6 $19 $32 $45 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.01$-7.99$-13.05$-5.16-----
Avg Forecast$-10.20$-6.93$-13.84$-4.27$2.19$9.99$18.54$26.94$34.47
High Forecast$-9.02$-6.13$-10.14$-3.65$3.24$17.75$35.69$34.50$42.05
Low Forecast$-12.34$-8.38$-16.90$-6.65$0.91$3.87$7.41$13.79$24.60
Surprise %-99.90%15.30%-5.71%20.84%-----

Revenue Forecast

$0 $2B $3B $5B $6B $8B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$44.80M$497.28M$410.75M$1.23B-----
Avg Forecast$71.20M$510.21M$441.26M$1.21B$2.17B$3.32B$4.40B$5.38B$6.49B
High Forecast$82.66M$592.33M$516.41M$1.22B$2.20B$3.80B$4.52B$5.54B$7.58B
Low Forecast$64.86M$464.78M$350.58M$1.18B$2.14B$2.82B$4.28B$5.21B$5.06B
Surprise %-37.08%-2.54%-6.92%1.38%-----

Net Income Forecast

$-1B $-300M $400M $1B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-650.55M$-408.26M$-709.59M$-295.05M-----
Avg Forecast$-583.25M$-396.15M$-173.12M$-268.11M$118.49M$647.04M$1.30B$1.79B$1.97B
High Forecast$-515.74M$-350.29M$-54.70M$-84.72M$185.18M$1.01B$2.04B$1.97B$2.40B
Low Forecast$-705.29M$-479.04M$-291.53M$-451.51M$51.81M$221.00M$423.47M$788.32M$1.41B
Surprise %11.54%3.06%309.90%10.05%-----

ARGX Forecast FAQ

Is argenx SE stock a buy?

argenx SE stock has a consensus rating of Buy, based on 34 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 30 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that argenx SE is a favorable investment for most analysts.

What is argenx SE's price target?

argenx SE's price target, set by 34 Wall Street analysts, averages $796.75 over the next 12 months. The price target range spans from $699 at the low end to $850 at the high end, suggesting a potential 4.44% change from the previous closing price of $762.89.

How does argenx SE stock forecast compare to its benchmarks?

argenx SE's stock forecast shows a 4.44% upside, underperforming the average forecast for the healthcare stocks sector (13.55%) and underperforming the biotech stocks industry (49.00%).

What is the breakdown of analyst ratings for argenx SE over the past three months?

  • September 2025: 26.09% Strong Buy, 69.57% Buy, 4.35% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 26.09% Strong Buy, 69.57% Buy, 4.35% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 30.43% Strong Buy, 65.22% Buy, 4.35% Hold, 0% Sell, 0% Strong Sell.

What is argenx SE’s EPS forecast?

argenx SE's average annual EPS forecast for its fiscal year ending in December 2024 is $2.19, marking a -142.44% decrease from the reported $-5.16 in 2023. Estimates for the following years are $9.99 in 2025, $18.54 in 2026, $26.94 in 2027, and $34.47 in 2028.

What is argenx SE’s revenue forecast?

argenx SE's average annual revenue forecast for its fiscal year ending in December 2024 is $2.17B, reflecting a 76.93% increase from the reported $1.23B in 2023. The forecast for 2025 is $3.32B, followed by $4.4B for 2026, $5.38B for 2027, and $6.49B for 2028.

What is argenx SE’s net income forecast?

argenx SE's net income forecast for the fiscal year ending in December 2024 stands at $118.49M, representing a -140.16% decrease from the reported $-295M in 2023. Projections indicate $647.04M in 2025, $1.3B in 2026, $1.79B in 2027, and $1.97B in 2028.